The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...

Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...

In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...

Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there is concerns about accessiblity.

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...